Results 201 to 210 of about 52,330 (263)

Carbapenems

Journal of Chemotherapy, 2013
To assess the relative strengths and weaknesses of carbapenems by considering their microbiological, clinical, pharmacokinetics and pharmacokinetic/pharmacodynamic (PK/PD) properties and defining optimal conditions of uses of the new generation of carbapenems.Literature review.Except for ertapenem, the spectrum of activity is similar for all ...
Emmanuel Boselli, Marie-Claude Saux
exaly   +3 more sources

Drug interaction between valproic acid and carbapenems in patients with epileptic seizures

open access: yesKaohsiung Journal of Medical Sciences, 2017
Valproic acid (VPA) is a widely used antiepileptic drug (AED). When carbapenems are concomitantly used with VPA, the serum levels of VPA may decrease and aggravate seizures. The aim of this study was to evaluate the risk factors associated with decreased
Nai-Ching Chen   +7 more
exaly   +2 more sources

Carbapenems in Pediatrics

Therapeutic Drug Monitoring, 2003
Antimicrobial resistance is increasing among bacterial pathogens. In particular, organisms producing extended spectrum beta-lactamase enzymes (ESBLs) and AmpC chromosomal beta-lactamase enzymes are resistant to third generation cephalosporins and pose a formidable challenge in the management of seriously ill patients.
Kassa, Ayalew   +3 more
openaire   +2 more sources

Evaluation of Carbapenems for Treatment of Multi- and Extensively Drug-Resistant Mycobacterium tuberculosis [PDF]

open access: yesAntimicrobial Agents and Chemotherapy, 2019
Multi-and extensively drug-resistant tuberculosis (M/XDR-TB) has become an increasing threat not only in countries where the TB burden is high but also in affluent regions, due to increased international travel and globalization.
Onno Akkerman
exaly   +3 more sources

Home - About - Disclaimer - Privacy